Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injection-Site Pain of Citrate vs Mannitol Formulations in Healthy Subjects
NCT05154968Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2021
- Primary completion
- Dec 2021
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Bronchitol (4 arms), sponsored by Eli Lilly and Company. Primary endpoint: Visual Analogue Scale (VAS) Pain Score at Injection Site at 0 months. Started Nov 2021; status: completed.
02
Drugs
Bronchitol
Beyond the preview
Go deeper on NCT05154968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05154968.